Direct Imaging of Drug Distribution and Target Engagement of the PARP Inhibitor Rucaparib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Direct Imaging of Drug Distribution and Target Engagement of the PARP Inhibitor Rucaparib

Published:2018-03-23 Issue:8 Volume:59 Page:1316-1320
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Kossatz Susanne,Carney Brandon,Farley Christopher,Weber Wolfgang A.,Drain Charles M.,Reiner Thomas

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference11 articles.

1. Molecular Imaging of PARP

2. Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo

3. PARPi-FL - a Fluorescent PARP1 Inhibitor for Glioblastoma Imaging

4. PARP inhibition: PARP1 and beyond

5. Toward Understanding Tryptophan Fluorescence in Proteins

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer;EJNMMI Research;2022-09-14

2. [18F]-Labeled PARP-1 PET imaging of PSMA targeted alpha particle radiotherapy response;Scientific Reports;2022-07-29

3. Imaging PARP with [18F]rucaparib in pancreatic cancer models;European Journal of Nuclear Medicine and Molecular Imaging;2022-05-26

4. Evaluation of phototoxicity induced by the anticancer drug rucaparib;Scientific Reports;2022-03-02

5. DoE Optimization Empowers the Automated Preparation of Enantiomerically Pure [18F]Talazoparib and its In Vivo Evaluation as a PARP Radiotracer;Journal of Medicinal Chemistry;2021-10-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3